{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:12:55Z","timestamp":1762621975171,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vhri.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T22:16:57Z","timestamp":1510179417000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months)"],"prefix":"10.1016","volume":"14","author":[{"given":"Claudia","family":"Felipe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio","family":"Tedesco-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Ferreira Brigido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrieli","family":"Bessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Ruppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayara","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Cristelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suelen","family":"Stopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Fahham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Medina-Pestana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2017.08.009_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1525-1594.2002.00916.x","article-title":"End-stage renal disease in the developing world","volume":"26","author":"Barsoum","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.vhri.2017.08.009_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1525-1594.2002.07061.x","article-title":"Overview: end-stage renal disease in the developing world","volume":"26","author":"Barsoum","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.vhri.2017.08.009_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10198-014-0579-3","article-title":"Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany","volume":"16","author":"J\u00fcrgensen","year":"2015","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.vhri.2017.08.009_bib4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marc\u00e9n","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.vhri.2017.08.009_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1034\/j.1600-6143.2003.00069.x","article-title":"The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis","volume":"3","author":"Schnitzler","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vhri.2017.08.009_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.vhri.2017.08.009_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2014challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.vhri.2017.08.009_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.tp.0000183970.71366.da","article-title":"Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"81","author":"Strippoli","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.vhri.2017.08.009_bib9","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/ajt.13327","article-title":"Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses","volume":"15","author":"Tedesco-Silva","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vhri.2017.08.009_bib10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/TP.0000000000001831","article-title":"Excellence and efficiency through a structured large scale approach: the Hospital Do Rim in S\u00e3o Paulo, Brazil","volume":"101","author":"Medina Pestana","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.vhri.2017.08.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20620","article-title":"Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model","volume":"20","author":"Jones-Hughes","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vhri.2017.08.009_bib12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/TP.0000000000000828","article-title":"An overview of the current status of organ donation and transplantation in Brazil","volume":"99","author":"Garcia","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.vhri.2017.08.009_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.transproceed.2007.12.016","article-title":"Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection","volume":"40","author":"Khosroshahi","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.vhri.2017.08.009_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00007890-200202150-00025","article-title":"Short course induction immunosuppression with thymoglobulin for renal transplant recipients","volume":"73","author":"Agha","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.vhri.2017.08.009_bib15","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vhri.2017.08.009_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","article-title":"State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3","volume":"15","author":"Siebert","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2017.08.009_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/027298902400448867","article-title":"Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease","volume":"22","author":"Briggs","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vhri.2017.08.009_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2017.08.009_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajt.12006","article-title":"CMV: prevention, diagnosis and therapy","volume":"13","author":"Kotton","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vhri.2017.08.009_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00007890-200010150-00018","article-title":"Increased impact of acute rejection on chronic allograft failure in recent era","volume":"70","author":"Meier-Kriesche","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.vhri.2017.08.009_bib21","first-page":"105","article-title":"Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells","volume":"148","author":"Waldman","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vhri.2017.08.009_bib22","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1600-6143.2012.03994.x","article-title":"ZEUS Study Investigators. Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study","volume":"12","author":"Budde","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vhri.2017.08.009_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2007040495","article-title":"Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation","volume":"19","author":"Earnshaw","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vhri.2017.08.009_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/TRRM.S12217","article-title":"Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation","volume":"3","author":"Tedesco-Silva","year":"2011","journal-title":"Transplant Res Risk Manage"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109917300675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109917300675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:10:12Z","timestamp":1761941412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109917300675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"alternative-id":["S2212109917300675"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2017.08.009","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months)","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research (ISPOR).","name":"copyright","label":"Copyright"}]}}